A few studies have investigated the variation of PD-L1 immunostaining after neoadjuvant chemotherapy and explored the association between chemotherapy response, prognosis, and the increase or decrease of PD-L1 expression in cancer patients [25, 26]. Here, CD274 is linked to cancer.